About the Cancer and Aging Session
- Mechanisms of Cancer in the Aging Population
- Geriatric Oncology: Tailoring Treatments for Older Adults
- Interactions Between Aging and Cancer Therapies
- Epigenetic Changes in Aging and Cancer
Aging is a significant risk factor for cancer, with most diagnoses occurring in older adults. As we age, genetic mutations accumulate, and immune system efficiency declines, increasing cancer susceptibility. Cellular senescence, an aging hallmark, promotes a pro-inflammatory environment, contributing to tumor development.
For older patients, cancer treatment poses unique challenges. Comorbidities and reduced physiological reserves often limit the feasibility of aggressive therapies. Advances in geriatric oncology are now tailoring treatments to the specific needs of aging individuals, focusing on balancing efficacy and quality of life.
Studying the interplay between cancer and aging not only enhances understanding of disease progression but also drives innovations in early detection, prevention, and personalized care for an aging global population.
Topics Covered in Cancer and Aging
Mechanisms of Cancer in Older Adults
Geriatric Oncology Assessment
Treatment Tolerance in Ageing
Age-Related Epigenetic Change
Comorbidity and Polypharmacy
Functional Status and Frailty
Related Scientific Sessions at CIOC 2027
Why Attend the Cancer and Aging Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Cancer and Aging work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Cancer and Aging research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Cancer and Aging track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Cancer and Aging Conference 2027 — FAQs
What is the Cancer and Aging track at CIOC 2027?
The Cancer and Aging track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Cancer and Aging. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Cancer and Aging sessions?
Cancer researchers and clinicians, educators and students with an interest in Cancer and Aging are all welcome — whether presenting or attending.
Can I present my research in the Cancer and Aging track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Cancer and Aging sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Cancer and Aging track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.